CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $139,087,138 | -22.7% | 6,371,376 | +12.5% | 0.00% | -25.0% |
Q2 2023 | $180,012,465 | +20.5% | 5,662,550 | -7.6% | 0.00% | 0.0% |
Q1 2023 | $149,427,286 | -21.5% | 6,126,580 | +1.5% | 0.00% | -20.0% |
Q4 2022 | $190,453,060 | +14.7% | 6,038,461 | +2.8% | 0.01% | 0.0% |
Q3 2022 | $165,999,000 | +25.3% | 5,874,001 | +17.2% | 0.01% | +25.0% |
Q2 2022 | $132,529,000 | -21.3% | 5,012,420 | +4.2% | 0.00% | 0.0% |
Q1 2022 | $168,388,000 | +8.2% | 4,809,693 | +0.2% | 0.00% | 0.0% |
Q4 2021 | $155,677,000 | +12.4% | 4,801,837 | +2.3% | 0.00% | +33.3% |
Q3 2021 | $138,448,000 | +53.3% | 4,693,159 | +33.1% | 0.00% | +50.0% |
Q2 2021 | $90,304,000 | +103.7% | 3,524,716 | +9.2% | 0.00% | +100.0% |
Q1 2021 | $44,323,000 | -15.0% | 3,228,141 | +2.6% | 0.00% | -50.0% |
Q4 2020 | $52,162,000 | – | 3,146,074 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |